Insulet Corporation (PODD) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, Insulet Corporation has achieved a revenue compound annual growth rate (CAGR) of 23.0%, while earnings have grown at 180.1% CAGR.
The company's net profit margin stands at 10.4%, showing healthy profitability.
Historical revenue and profitability trends for Insulet Corporation
The chart above illustrates Insulet Corporation's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Insulet Corporation's business.
How efficiently Insulet Corporation converts revenue into profit
Profit margins reveal how much of each dollar of revenue Insulet Corporation retains at different stages:
A net margin between 5-15% shows Insulet Corporation maintains reasonable profitability.
Analyst estimates and forward-looking indicators
Wall Street analysts project Insulet Corporation to continue growing earnings in the coming year. The consensus analyst rating is 4.5833 based on 24 analysts.
Based on our comprehensive analysis, Insulet Corporation (PODD) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Insulet Corporation's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Insulet Corporation stacks up against similar companies
Explore growth analysis for top stocks
Related: PODD Valuation, PODD Dividend, PODD Financial Health
Compare: PODD vs AAPL, PODD vs MSFT, PODD vs GOOGL